Reference
Wang J, et al. PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Journal of Hematology and Oncology 9: 84, No. 1, 9 Sep 2016. Available from: URL: http://doi.org/10.1186/s13045-016-0317-7 - China
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1754, 45 (2019). https://doi.org/10.1007/s40278-019-62278-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-62278-z